TOMDF (Todos Medical) YoY EBITDA Growth: 60.00% (As of Sep. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Todos Medical YoY EBITDA Growth?

Todos Medical TOMDF -90.00% YoY EBITDA Growth is 60.00% as of Sep. 2022.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Todos Medical's YoY EBITDA Growth for the quarter that ended in Sep. 2022 was 60.00%.

Todos Medical's EBITDA per Share for the three months ended in Sep. 2022 was $-0.00.

Todos Medical YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Todos Medical's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Todos Medical YoY EBITDA Growth Chart

Todos Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
YoY EBITDA Growth
Get a 7-Day Free Trial -111.11 68.42 -1,866.67 46.61 66.67

Todos Medical Quarterly Data
Dec15 Dec16 Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.00 0.00 66.67 -133.33 60.00

Todos Medical YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Todos Medical's YoY EBITDA Growth for the fiscal year that ended in Dec. 2021 is calculated as:

YoY EBITDA Growth (A: Dec. 2021 )
=(EBITDA per Share (A: Dec. 2021 )-EBITDA per Share (A: Dec. 2020 ))/ | EBITDA per Share (A: Dec. 2020 ) |
=(-0.021--0.063)/ | -0.063 |
=66.67 %

Todos Medical's YoY EBITDA Growth for the quarter that ended in Sep. 2022 is calculated as:

YoY EBITDA Growth (Q: Sep. 2022 )
=(EBITDA per Share (Q: Sep. 2022 )-EBITDA per Share (Q: Sep. 2021 )) / | EBITDA per Share (Q: Sep. 2021 )) |
=(-0.002--0.005)/ | -0.005 |
=60.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 60.00% mean?
Todos Medical (TOMDF) has a YoY EBITDA Growth of 60.00% as of Sep. 2022. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Todos Medical and its competitors.
Is Todos Medical's YoY EBITDA Growth too high?
Todos Medical's current YoY EBITDA Growth is 60.00%.
How does Todos Medical's YoY EBITDA Growth compare to NDRA and IDXG?
Todos Medical's YoY EBITDA Growth of 60.00% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Medical Diagnostics & Research company?
A good YoY EBITDA Growth depends on the Medical Diagnostics & Research industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Todos Medical and its competitors. Todos Medical's current YoY EBITDA Growth is 60.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Todos Medical stock overvalued right now?
Todos Medical (TOMDF) has a current YoY EBITDA Growth of 60.00%. The current YoY EBITDA Growth is 60.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Todos Medical (TOMDF), the current YoY EBITDA Growth is 60.00% as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Todos Medical Business Description

Address 121 Derech Menachem Begin, 30th Floor, Tel Aviv, ISR, 6701203
Todos Medical Ltd is an in vitro diagnostics company. Its operating segments are Breast Cancer Test, Alzheimer's, and COVID-19 testing. The company generates all of its revenue from the United States.